Answer
Avalglucosidase alfa (Nexviadyme) has no available data on its presence in human milk or effects on milk production or breastfed infants, so breastfeeding safety is unknown and use is justified only if potential maternal benefits outweigh potential risks, including those to the breastfed child.
Sources for this answer
- Nexviadyme 100 mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked